$5.30
2.91121.97%
Last update: Nov 10, 12:16 PM
PepGen Inc (PEPG) Stock Price, Quote, News & History
PEPGNASDAQ
PepGen stock drops after Phase 2 low-dose data show limited splicing correction; higher-dose cohorts and FDA hold remain key focus areas.
You can purchase shares of PepGen (NASDAQ:PEPG) through any online brokerage.
Other companies in PepGen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
PepGen has a consensus price target of $10.00.
The stock price for PepGen (NASDAQ: PEPG) is $5.305 last updated November 10, 2026 at 12:16 PM EST.
There are no upcoming dividends for PepGen.
PepGen does not have any upcoming earnings scheduled.
There is no upcoming split for PepGen.
PepGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery...
